DZ Bank analyst Peter Spengler upgraded Bayer (BAYRY) to Hold from Sell with a EUR 44 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bayer Targets India Hemophilia Market With New Real World Safety Study
- Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
- Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
- Bayer says Europe may need to pay more for medicines, FT reports
- Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects